Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

worst case? B has some benefit for patients in stopping disease spread, and it succeeds in a trial designed to show this benefit. Unfortunately, the company trial was for patients who already had widespread disease, and the trial fails, and there is no money for another. B for UC oral trial also has no funding. The company folds. The successful trial is run by the company that picks up Brilacidin for nothing just as did IP before.